Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jiyang Han, Yan Li & Xumei Wang. (2017) Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia. Neuropsychiatric Disease and Treatment 13, pages 2935-2943.
Read now
Read now
Rona Jeannie Roberts, Lillian Jan Findlay, Peggy L El-Mallakh & Rif S El-Mallakh. (2016) Update on schizophrenia and bipolar disorder: focus on cariprazine. Neuropsychiatric Disease and Treatment 12, pages 1837-1842.
Read now
Read now
Jonathan Tomas Lockwood & Gary Remington. (2015) Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials. Expert Opinion on Emerging Drugs 20:3, pages 407-421.
Read now
Read now
Articles from other publishers (67)
Julien Lalut, Sofiane Hocine, Gaëtan Maertens, Miguel Vilchis-Reyes & Stephen Hanessian. (2024) Design and synthesis of fused azacyclic and azaspirocyclic γ-lactams targeting dopaminergic D2/D4 receptors. Journal of Molecular Structure 1299, pages 137104.
Crossref
Crossref
Roberto Zatz & Gilberto De Nucci. (2024) Endothelium-Derived Dopamine and 6-Nitrodopamine in the Cardiovascular System. Physiology 39:1, pages 44-59.
Crossref
Crossref
Yuriy M. Kositsyn, Murilo S. de Abreu, Tatiana O. Kolesnikova, Alexey A. Lagunin, Vladimir V. Poroikov, Hasmik S. Harutyunyan, Konstantin B. Yenkoyan & Allan V. Kalueff. (2023) Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies. International Journal of Molecular Sciences 24:11, pages 9482.
Crossref
Crossref
Simon Bergsma, Efthymios Poulios, Nikolaos Charalampogiannis, Odetta Andraws & Spyridon Achinas. (2022) Cation-𝜋 Interaction as a Key Player in Healthcare: A Mini-Review. Digital Medicine and Healthcare Technology 2022, pages 1-13.
Crossref
Crossref
Marcus Saarinen, Ioannis Mantas, Ivana Flais, Richard Ågren, Kristoffer Sahlholm, Mark J. Millan & Per Svenningsson. (2022) TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT1A receptor agonist SEP-363856. Neuropsychopharmacology 47:13, pages 2319-2329.
Crossref
Crossref
Kirsten T. Tolentino, Viktoriya Mashinson, Manish K. Sharma, Yashpal S. Chhonker, Daryl J. Murry & Corey R. Hopkins. (2022) From dopamine 4 to sigma 1: Synthesis, SAR and biological characterization of a piperidine scaffold of σ1 modulators. European Journal of Medicinal Chemistry 244, pages 114840.
Crossref
Crossref
Faizul Azam & Martiniano Bello. (2022) Dynamic and thermodynamic impact of L94A, W100A, and W100L mutations on the D2 dopamine receptor bound to risperidone. RSC Advances 12:53, pages 34359-34368.
Crossref
Crossref
Mohammed H. Sarikahya, Samantha Cousineau, Marta De Felice, Kendrick Lee, Karen KW Wong, Marieka V. DeVuono, Tony Jung, Mar Rodríguez-Ruiz, Tsun Hay Jason Ng, Dana Gummerson, Emma Proud, Daniel B. Hardy, Ken K.-C. Yeung, Walter Rushlow & Steven R. Laviolette. (2022) Prenatal THC Exposure Induces Sex-Dependent Neuropsychiatric Endophenotypes in Offspring and Long-Term Disruptions in Fatty-Acid Signaling Pathways Directly in the Mesolimbic Circuitry. eneuro 9:5, pages ENEURO.0253-22.2022.
Crossref
Crossref
Asako Yoritaka, Tetsuo Hayashi, Keiko Fusegi, Rie Inami & Nobutaka Hattori. (2022) Prospective Five-Year Follow-Up of Patients with Schizophrenia Suspected with Parkinson’s Disease. Parkinson's Disease 2022, pages 1-8.
Crossref
Crossref
Jorge Sebiani Moreira. (2022) Revisión de Literatura Sobre Anormalidades Neurobiológicas en la Esquizofrenia. PsicoInnova 5:2, pages 18-30.
Crossref
Crossref
Ee Von Moo, Kasper Harpsøe, Alexander S. Hauser, Ikuo Masuho, Hans Bräuner-Osborne, David E. Gloriam & Kirill A. Martemyanov. (2022) Ligand-directed bias of G protein signaling at the dopamine D2 receptor. Cell Chemical Biology 29:2, pages 226-238.e4.
Crossref
Crossref
Paula Jhoana Escobedo-Aedo, Ana Forjan-González, Adela Sánchez-Escribano Martínez, Verónica González Ruiz-Ruano, Sergio Sánchez-Alonso, Laura Mata-Iturralde, Laura Muñoz-Lorenzo, Enrique Baca-García, Anthony S. David & Javier-David Lopez-Morinigo. (2022) Investigating the Role of Insight, Decision-Making and Mentalizing in Functional Outcome in Schizophrenia: A Cross-Sectional Study. Behavioral Sciences 12:2, pages 28.
Crossref
Crossref
Mary V. Seeman. (2022) Philip Seeman's contributions to the story of schizophrenia. Psychological Medicine, pages 1-3.
Crossref
Crossref
Wayne Hall. (2021) Why was early therapeutic research on psychedelic drugs abandoned?. Psychological Medicine 52:1, pages 26-31.
Crossref
Crossref
Peter Schönknecht. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
10
.
Peter Schönknecht. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1953
1962
.
Armand Guàrdia, Alexandre González-Rodríguez, Mary V. Seeman, Aida Álvarez, Francesc Estrada, Sidharta Acebillo, Javier Labad & José A. Monreal. (2021) Dopamine, Serotonin, and Structure/Function Brain Defects as Biological Bases for Treatment Response in Delusional Disorder: A Systematic Review of Cases and Cohort Studies. Behavioral Sciences 11:10, pages 141.
Crossref
Crossref
Han Zhou, Tao Hou, Zhenhua Gao, Xiujie Guo, Chaoran Wang, Jixia Wang, Yanfang Liu & Xinmiao Liang. (2021) Discovery of eight alkaloids with D1 and D2 antagonist activity in leaves of Nelumbo nucifera Gaertn. Using FLIPR assays. Journal of Ethnopharmacology 278, pages 114335.
Crossref
Crossref
Simone Patergnani, Massimo BonoraSelene Ingusci, Maurizio Previati, Saverio MarchiSilvia ZucchiniMariasole PerroneMariusz R. WieckowskiMassimiliano Castellazzi, Maura PugliattiCarlotta GiorgiMichele Simonato & Paolo Pinton. (2021) Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis. Proceedings of the National Academy of Sciences 118:24.
Crossref
Crossref
Donald J. AbrahamSeth Ablordeppey & Edward Ofori. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
69
.
Mark D. Tricklebank, Carol Tamminga, Andrew Grottick, Pierre M. Llorca, Silvia Gatti McArthur & Jean-Claude Martel. (2021) Editorial: Dopaminergic Alterations in Schizophrenia. Frontiers in Neuroscience 15.
Crossref
Crossref
Raphael P. Bacil, Estenio A. de O. Marcondes Filho, Kevin de A. Dias, Marcelo C. Portes, William R. de Araujo, Diogo Oliveira-Silva, Alcindo A. dos Santos & Silvia H.P. Serrano. (2021) The chemical interaction between the neurotransmitter dopamine and the antipsychotic drugs olanzapine and quetiapine. Journal of Electroanalytical Chemistry 881, pages 114946.
Crossref
Crossref
Kaja Blagotinšek Cokan, Maša Mavri, Catrin Sian Rutland, Sanja Glišić, Milan Senćanski, Milka Vrecl & Valentina Kubale. (2020) Critical Impact of Different Conserved Endoplasmic Retention Motifs and Dopamine Receptor Interacting Proteins (DRIPs) on Intracellular Localization and Trafficking of the D2 Dopamine Receptor (D2-R) Isoforms. Biomolecules 10:10, pages 1355.
Crossref
Crossref
Jie Yin, Kuang-Yui M. Chen, Mary J. Clark, Mahdi Hijazi, Punita Kumari, Xiao-chen Bai, Roger K. Sunahara, Patrick Barth & Daniel M. Rosenbaum. (2020) Structure of a D2 dopamine receptor–G-protein complex in a lipid membrane. Nature 584:7819, pages 125-129.
Crossref
Crossref
Jean Claude Martel & Silvia Gatti McArthur. (2020) Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia. Frontiers in Pharmacology 11.
Crossref
Crossref
Miguel Perez de la Mora, Carlos Hernandez-Mondragon, Minerva Crespo-Ramirez, José Rejon-Orantes, Dasiel O. Borroto-Escuela & Kjell Fuxe. (2020) Conventional and Novel Pharmacological Approaches to Treat Dopamine-Related Disorders: Focus on Parkinson’s Disease and Schizophrenia. Neuroscience 439, pages 301-318.
Crossref
Crossref
R. Pérez-Isidoro & M. Costas. (2020) The effect of neuroleptic drugs on DPPC/sphingomyelin/cholesterol membranes. Chemistry and Physics of Lipids 229, pages 104913.
Crossref
Crossref
Tiffany A. Greenwood. (2020) Creativity and Bipolar Disorder: A Shared Genetic Vulnerability. Annual Review of Clinical Psychology 16:1, pages 239-264.
Crossref
Crossref
Juan Francisco Bada Juarez, Juan C. Muñoz-García, Rosana Inácio dos Reis, Alistair Henry, David McMillan, Marco Kriek, Martyn Wood, Catherine Vandenplas, Zara Sands, Luis Castro, Richard Taylor & Anthony Watts. (2020) Detergent-free extraction of a functional low-expressing GPCR from a human cell line. Biochimica et Biophysica Acta (BBA) - Biomembranes 1862:3, pages 183152.
Crossref
Crossref
Shuyu Liu, Jiarui Wu, Yingli Zhu, Wei Zhou, Xinkui Liu, Changgeng Fu, Zhiguo Ding, Lishan Xu, Ying Zhang, Ziqi Meng, Mengwei Ni, Shanshan Jia, Jingyuan Zhang & Siyu Guo. (2020) Network pharmacology-based approach to investigate the mechanisms of Shenqi Fuzheng injection in the treatment of breast cancer. European Journal of Integrative Medicine 34, pages 101064.
Crossref
Crossref
Yibo Li, Jianxing Hu, Yanxing Wang, Jielong Zhou, Liangren Zhang & Zhenming Liu. (2019) DeepScaffold: A Comprehensive Tool for Scaffold-Based De Novo Drug Discovery Using Deep Learning. Journal of Chemical Information and Modeling 60:1, pages 77-91.
Crossref
Crossref
Michael Silkstone & Stefan M. Brudzynski. (2020) Dissimilar interaction between dopaminergic and cholinergic systems in the initiation of emission of 50-kHz and 22-kHz vocalizations. Pharmacology Biochemistry and Behavior 188, pages 172815.
Crossref
Crossref
Roksana Zakharyan, Hovsep Ghazaryan, Lenka Kocourkova, Andranik Chavushyan, Artur Mkrtchyan, Veronika Zizkova, Arsen Arakelyan & Martin Petrek. (2020) Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia. Archives of Medical Research 51:1, pages 13-20.
Crossref
Crossref
Verónica García Walker. (2019) The Life Course Paradigm as a Lens for Holistic Nursing Research in Older Adults Diagnosed With Schizophrenia. Journal of Holistic Nursing 37:4, pages 366-380.
Crossref
Crossref
Beatriz Bueschbell, Carlos Barreto, António Preto, Anke Schiedel & Irina Moreira. (2019) A Complete Assessment of Dopamine Receptor- Ligand Interactions through Computational Methods. Molecules 24:7, pages 1196.
Crossref
Crossref
Youjun Xu, Kangjie Lin, Shiwei Wang, Lei Wang, Chenjing Cai, Chen Song, Luhua Lai & Jianfeng Pei. (2019) Deep learning for molecular generation. Future Medicinal Chemistry 11:6, pages 567-597.
Crossref
Crossref
Ryan J Dougherty. (2019) The Psychological Management of the Poor: Prescribing Psychoactive Drugs in the Age of Neoliberalism. Journal of Social Issues 75:1, pages 217-237.
Crossref
Crossref
Alessandro Bonifazi, Hideaki Yano, Adrian M. Guerrero, Vivek Kumar, Alexander F. Hoffman, Carl R. Lupica, Lei Shi & Amy Hauck Newman. (2019)
Novel and Potent Dopamine D
2
Receptor Go-Protein Biased Agonists
. ACS Pharmacology & Translational Science 2:1, pages 52-65.
Crossref
Crossref
Debra Boyd-Kimball, Katelyn Gonczy, Benjamin Lewis, Thomas Mason, Nicole Siliko & Jacob Wolfe. (2018) Classics in Chemical Neuroscience: Chlorpromazine. ACS Chemical Neuroscience 10:1, pages 79-88.
Crossref
Crossref
Gaëtan Maertens, Oscar M. Saavedra, Vito Vece, Miguel A. Vilchis Reyes, Sofiane Hocine, Esat Öney, Bertrand Goument, Olivier Mirguet, Arnaud Le Tiran, Philippe Gloanec & Stephen Hanessian. (2018) Design and synthesis of bridged piperidine and piperazine isosteres. Bioorganic & Medicinal Chemistry Letters 28:15, pages 2627-2630.
Crossref
Crossref
Nicola Latronico. (2018) Haloperidol and delirium in the ICU: the finger pointing to the moon. Intensive Care Medicine 44:8, pages 1346-1348.
Crossref
Crossref
Ramin Ekhteiari Salmas, Philip Seeman, Matthias Stein & Serdar Durdagi. (2018)
Structural Investigation of the Dopamine-2 Receptor Agonist Bromocriptine Binding to Dimeric D2
High
R and D2
Low
R States
. Journal of Chemical Information and Modeling 58:4, pages 826-836.
Crossref
Crossref
Euitae Kim. (2018) Treatment-Resistant Schizophrenia : Pathophysiology and Treatment. Journal of Korean Neuropsychiatric Association 57:3, pages 230.
Crossref
Crossref
Amy E. Moritz, R. Benjamin Free & David R. Sibley. (2018) Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds. Cellular Signalling 41, pages 75-81.
Crossref
Crossref
Lillian Jan Findlay, Peggy L. El-Mallakh & Rif S. El-Mallakh. (2017) Cariprazine for the Treatment of Bipolar Disorder. Perspectives in Psychiatric Care 53:3, pages 148-155.
Crossref
Crossref
R. Abboud, C. Noronha & V.A. Diwadkar. (2020) Motor system dysfunction in the schizophrenia diathesis: Neural systems to neurotransmitters. European Psychiatry 44, pages 125-133.
Crossref
Crossref
Anil Kumar, Monu Yadav, Milind Parle, Sameer Dhingra & Dinesh K. Dhull. (2017) Potential drug targets and treatment of schizophrenia. Inflammopharmacology 25:3, pages 277-292.
Crossref
Crossref
Alessandro Bonifazi, Hideaki Yano, Michael P. Ellenberger, Ludovic Muller, Vivek Kumar, Mu-Fa Zou, Ning Sheng Cai, Adrian M. Guerrero, Amina S. Woods, Lei Shi & Amy Hauck Newman. (2017)
Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D
2
Receptor (D
2
R) Biased Agonism
. Journal of Medicinal Chemistry 60:7, pages 2890-2907.
Crossref
Crossref
X Xiao, H Chang & M Li. (2017) Molecular mechanisms underlying noncoding risk variations in psychiatric genetic studies. Molecular Psychiatry 22:4, pages 497-511.
Crossref
Crossref
Nikhil M. Urs, Sean M. Peterson & Marc G. Caron. (2017) New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy. Biological Psychiatry 81:1, pages 78-85.
Crossref
Crossref
C?cile Monpays, Jessica Deslauriers, Philippe Sarret & Sylvain Grignon. (2016) Mitochondrial Dysfunction in Schizophrenia: Determination of Mitochondrial Respiratory Activity in a Two-Hit Mouse Model. Journal of Molecular Neuroscience 59:4, pages 440-451.
Crossref
Crossref
Mu-Fa Zou, Thomas M. Keck, Vivek Kumar, Prashant Donthamsetti, Mayako Michino, Caitlin Burzynski, Catherine Schweppe, Alessandro Bonifazi, R. Benjamin Free, David R. Sibley, Aaron Janowsky, Lei Shi, Jonathan A. Javitch & Amy Hauck Newman. (2016)
Novel Analogues of (
R
)-5-(Methylamino)-5,6-dihydro-4
H
-imidazo[4,5,1-
ij
]quinolin-2(1
H
)-one (Sumanirole) Provide Clues to Dopamine D
2
/D
3
Receptor Agonist Selectivity
. Journal of Medicinal Chemistry 59:7, pages 2973-2988.
Crossref
Crossref
Tiffany A. Greenwood. (2016) Positive Traits in the Bipolar Spectrum: The Space between Madness and Genius. Complex Psychiatry 2:4, pages 198-212.
Crossref
Crossref
Jenny Paola Berrío Sánchez & Bart A. Ellenbroek. 2017. Non-medical and illicit use of psychoactive drugs. Non-medical and illicit use of psychoactive drugs
1
16
.
Melkaye G. Melka, Christina A. Castellani, Richard O’Reilly & Shiva M. Singh. (2015) Insights into the origin of DNA methylation differences between monozygotic twins discordant for schizophrenia. Journal of Molecular Psychiatry 3:1.
Crossref
Crossref
Katherine A. Lyseng-Williamson. (2015) Clotiapine in schizophrenia: a guide to its use. Drugs & Therapy Perspectives 31:11, pages 365-371.
Crossref
Crossref
Ceren Acar, Mustafa Mert S?zen, Harika G?z?kara, K?bra Orman & ??kr? Kartalc?. (2015) Lack of association between catechol-Omethyltransferase and schizophrenia in a Turkish population. Turkish Journal of Biochemistry 40:3.
Crossref
Crossref
Jan Dirk Blom. 2015. The Human Auditory System - Fundamental Organization and Clinical Disorders. The Human Auditory System - Fundamental Organization and Clinical Disorders
433
455
.
Ralf Brisch, Arthur Saniotis, Rainer Wolf, Hendrik Bielau, Hans-Gert Bernstein, Johann Steiner, Bernhard Bogerts, Anna Katharina Braun, Zbigniew Jankowski, Jaliya Kumaritlake, Maciej Henneberg & Tomasz Gos. (2014) The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue. Frontiers in Psychiatry 5.
Crossref
Crossref
Hongzhu Li, Can Wei, Jun Gao, Shuzhi Bai, Hongxia Li, Yajun Zhao, Hong Li, Liping Han, Ye Tian, Guangdong Yang, Rui Wang, Lingyun Wu & Changqing Xu. (2014) Mediation of dopamine D2 receptors activation in post-conditioning-attenuated cardiomyocyte apoptosis. Experimental Cell Research 323:1, pages 118-130.
Crossref
Crossref
Jack Ferrier. (2014) Domperidone as an unintended antipsychotic. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 147:2, pages 76-77.
Crossref
Crossref
Philip Seeman. (2013) Clozapine, a Fast-Off-D2 Antipsychotic. ACS Chemical Neuroscience 5:1, pages 24-29.
Crossref
Crossref
Xiong Wang, Li Ma, En-jing Zhang, Ji-li Zou, Hao Guo, Si-wei Peng & Jin-hu Wu. (2014)
Water Extract of
Fructus Hordei Germinatus
Shows Antihyperprolactinemia Activity via Dopamine D2 Receptor
. Evidence-Based Complementary and Alternative Medicine 2014, pages 1-7.
Crossref
Crossref
Mary V. Seeman & Philip Seeman. (2014) Is schizophrenia a dopamine supersensitivity psychotic reaction?. Progress in Neuro-Psychopharmacology and Biological Psychiatry 48, pages 155-160.
Crossref
Crossref
Amy CC Kao & Daniel J Müller. (2013) Genetics of antipsychotic-induced weight gain: update and current perspectives. Pharmacogenomics 14:16, pages 2067-2083.
Crossref
Crossref
Melkaye G Melka, Christina A Castellani, Benjamin I Laufer, N Rajakumar, Richard O’Reilly & Shiva M Singh. (2013) Olanzapine induced DNA methylation changes support the dopamine hypothesis of psychosis. Journal of Molecular Psychiatry 1:1.
Crossref
Crossref
Philip Seeman. (2013) Schizophrenia thalamus imaging: Low benzamide binding to dopamine D2 receptors suggests fewer D2Short receptors and fewer presynaptic terminals. Psychiatry Research: Neuroimaging 214:3, pages 175-180.
Crossref
Crossref